Lenvatinib in Second Line Endometrial Carcinoma
Clinical trial NCT03005015 · WITHDRAWN
Trial details
- NCT number
- NCT03005015
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-01
- Primary completion
- 2020-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.